Curve Biosciences
Latest round
- Series A
Last raised
- May 2024
Total raised
- $21M
Investors
- 5
About Curve Biosciences
Based in California, US, and founded in 2021, Curve Biosciences, Inc. operates as a biotechnology company that focuses on developing precision medicine that targets the biological changes in tissues that result in the development and progression of chronic diseases. In May 2024, Curve Biosciences, Inc. In October 2025, Curve Biosciences, Inc. The company leverages a chronic disease tissue atlas and a data-driven approach to discover and develop precision medicine solutions that target chronic illnesses such as liver disease, endometriosis, and inflammatory bowel disease.
Who invested in Curve Biosciences
5 investors across 2 rounds
See all investors in Curve Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Curve Biosciences
Who invested in Curve Biosciences?
Curve Biosciences has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curve Biosciences raised?
Curve Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Curve Biosciences last raise money?
Curve Biosciences's most recent round on record is a Series A, in May 2024.
What does Curve Biosciences do?
Based in California, US, and founded in 2021, Curve Biosciences, Inc.
Where is Curve Biosciences headquartered?
Curve Biosciences is headquartered in Dallas, US.
Which VCs invest in companies like Curve Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Curve Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Curve Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.